Universal problem
Healthcare knowledge, capabilities, referrals, research and access remain fragmented across institutions and systems.
INVESTOR ROOMDisease Intelligence is not a directory.
Disease Intelligence is not a directory.
It is an infrastructure thesis.
The investment case is to build a governed intelligence layer connecting disease, capability, evidence, healthcare organisations, research and access—then monetise the workflows and institutional intelligence built on top.
THE THESIS
Seven reasons this could become a very large platform—if validated.
Multi-sided network
Patients, professionals, providers, researchers, life sciences and governments all need different views of the same underlying intelligence.
Recurring enterprise spend
Hospital SaaS, life-sciences intelligence, public-sector licences, APIs and white-label infrastructure support recurring B2B revenue.
Data compounding
Verified capabilities, provenance, network relationships and aggregate usage signals can improve the platform over time when lawfully governed.
Workflow distribution
Referral, verification, trial/site, evidence and monitoring workflows can make DI operational—not merely informational.
Interoperability
FHIR-shaped models and EHDS-aware architecture can help DI connect rather than become another isolated silo.
Trust infrastructure
Evidence lineage, freshness, conflicts, consent and permissions can differentiate DI from opaque generic AI.
Capital efficiency path
Prototype → pilots → non-dilutive funding → institutional revenue → larger equity is a more credible sequence than funding everything at once.
WHAT CAPITAL WOULD FUND
Milestones, not vague “AI development”.
Database-backed graph, authentication, organisation workspaces, search, APIs and audit trails.
Governed ingestion, ontology mapping, entity resolution, provenance, freshness and conflict workflows.
Technical benchmarks, user studies, institutional pilots, workflow/economic measurement and safety evaluation.
Classification, privacy, DPIA, cyber security, quality-management and medical-device workstreams where applicable.
Hospital and life-sciences pilot sales, procurement readiness, onboarding and customer success.
Engineering, data/ontology, clinical informatics, product, regulatory, security and enterprise commercial leadership.